Search Results for 'license'
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Rigel, Grifols Enter License Agreement
To commercialize fostamatinib disodium hexahydrate in all potential indications in Europe and Turkey01.23.19
-
Breaking News | Collaborations & Alliances | Industry News
Recro Pharma Amends IV Meloxicam License Agreement with Alkermes
Reduces 2019 cash requirements by $30 Million; extends approval milestone payments over seven years12.26.18
-
Bio News | Collaborations & Alliances | Drug Development | Industry News | R&D
Orchard & SIRION Enter License Agreement
SIRION to provide Orchard with a license to its proprietary lentiviral transduction enhancer LentiBOOST™12.14.18
-
Bio News | Collaborations & Alliances | Industry News
PNI, Entos Enter License & Supply Agreement
PNI will provide its scale-up system, technology transfer and support the GMP manufacturing of Entos' lead candidate11.15.18
-
Bio News | Collaborations & Alliances | Drug Development | Industry News
Cytovance, Horizon Sign License Agreement
For the use of their HD-BIOP3 Suspension adapted GS null CHO K1 cells10.03.18
-
Takara Bio Granted Mfg. License From Sweden's Medical Authority
Allows for clinical-grade human embryonic stem cell line derivation and banking08.20.18
-
Drug Development | Industry News
Gemphire, Pfizer Amend Gemcabene License
Extends the deadline for the first commercial sale to April 202408.07.18
-
Bio News | Collaborations & Alliances | Industry News
I-Mab, ABL Bio Enter License Agreement
ABL Bio to in-license global rights to I-Mab's bispecific antibodies of undisclosed target with licensing payments of $100M07.27.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Aptose To License CG-806 from CrystalGenomics
The move comes after Aptose exercised the option under a 2016 Option Agreement05.07.18
-
Biologics, Proteins, Vaccines | Collaborations & Alliances | Drug Development | Industry News
Orbis, Daré Bioscience Enter License Agreement
Daré Bioscience can now license worldwide rights to Orbis' long-acting contraceptive products03.12.18
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Industry News | Preclinical Outsourcing
Abzena and OBI Pharma Sign ThioBridge License Agreement
Master services and clinical supply agreement to enable process development and manufacturing by Abzena07.14.17
